Dalbavancin for Bone and Joint Infections: A Two-Center Greek Real-World Retrospective Study

Bone and joint infections remain therapeutic challenges, usually requiring prolonged intravenous therapy and hospitalization. Dalbavancin, a long-acting lipoglycopeptide, offers a simplified alternative. We retrospectively analysed 83 patients treated with dalbavancin for osteomyelitis, spondylodisc...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Christina Petropoulou, Petros Ioannou, Georgios Eleftherakis, Stefania Papazisi, Christos Davoulos, Eugenia Drosou, Anastasia Spiliopoulou, Ekaterini Tsiata, Fotini Paliogianni, Diamantis Kofteridis, Markos Marangos, Stelios F. Assimakopoulos
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2025-10-01
Edice:	Pathogens
Témata:	dalbavancin osteomyelitis spondylodiscitis septic arthritis prosthetic joint infection Gram-positive bacteria
On-line přístup:	https://www.mdpi.com/2076-0817/14/11/1109
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!